Malaria Consortium’s recommendations for the Global Fund 2023 strategy
The recently published Global Fund Results Report highlights the devastating impact the COVID-19 pandemic has had on the fight aga......read more
Monoclonal antibodies: A breakthrough in the fight against malaria?
According to the 2020 World Malaria Report, in 2019 there were 229 million malaria infections and malaria claimed the lives of 409......read more
UK-Nigeria foreign policy in 2021: Rhetoric vs reality
In recent months, the UK government’s messaging on ‘Global Britain’ has increased, Cornwall has hosted the G7 summit and the......read more
Our research strategy for seasonal malaria chemoprevention
Malaria Consortium is launching a new seasonal malaria chemoprevention (SMC) research strategy. As a leading implementer of SMC, w......read more
Seasonal malaria chemoprevention and COVID-19: one year on
2020 was the most difficult year in living memory. Echoing the call of the World Health Organization (WHO), Malaria Consortium sup......read more
Publication snapshot of 2020
We have produced over 60 new publications covering a wide range of Malaria Consortium’s activities this year. From advocacy brie......read more
Our top blogs of 2020
In a challenging year for our operations across Africa and Asia, we have looked to communicate the breadth of Malaria Consortiumâ€......read more
Celebrating success – LLIN distribution in South Sudan during COVID-19
Working with the South Sudan National Malaria Control Programme (NMCP) and Population Services International (PSI), Malaria Consor......read more
Our statement on COVID-19 and SMC
This is a previous statement related to Malaria Consortium's response to the COVID-19 pandemic. See our latest statement on COVID-......read more
